Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Benzimidazole derivative containing alkoxy substituted pyridine

An ethoxyl and methoxyl technology, which is applied in the field of medicine, can solve the problems of large individual differences in pharmacokinetics, reducing surgical operation rates, affecting drug efficacy and pharmacokinetic parameters, etc.

Active Publication Date: 2012-08-29
SHANDONG XUANZHU PHARMA TECH CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After the 1970s, with the H 2 The discovery of gastric acid secretion inhibitors such as receptor blockers and proton pump inhibitors has created a new era of peptic ulcer treatment. These drugs have the characteristics of quick effect and high ulcer healing rate, which greatly reduces the surgical operation rate
However, the onset time of these drugs is slow, and the drug effect is not strong enough. It takes several doses (that is, a few days) to achieve the maximum acid-suppressing effect, and it may not be able to stably suppress acid for 24 hours. The time of taking the drug and eating may affect the effect of the drug. Pharmacokinetic parameters, individual differences in pharmacokinetics, and significant interactions with other drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Benzimidazole derivative containing alkoxy substituted pyridine
  • Benzimidazole derivative containing alkoxy substituted pyridine
  • Benzimidazole derivative containing alkoxy substituted pyridine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0102] Example 1 Preparation of 2-mercapto-4-methoxycarbonyl-benzimidazole

[0103] Put 10g (60mmol) of 2,3-diamino-benzoic acid methyl ester into the reaction flask, add 200ml of ethyl acetate, then add 12.8g (80mmol) of potassium ethoxysulfonate, and heat to reflux at 80°C for 4h. After the reaction was completed, cool to room temperature, pour the reaction solution into 200ml of ice water, stir evenly, adjust the pH to 3-4 with 4N hydrochloric acid, precipitate a solid, filter, wash with water until neutral, and vacuum-dry the filter cake to obtain 9.1g of the product. Rate: 73.2%.

Embodiment 2

[0104] Example 2 Preparation of 4-(3-methoxypropoxy)-2,3-dimethyl-N-pyridine oxide

[0105] Add 16.8g (100mmol) of 4-(3-methoxypropoxy)-2,3-dimethyl-N-pyridine oxide, 100ml of 1,3-propylene glycol monomethyl ether, powder Potassium carbonate 20g, heated and stirred under reflux for 12h, stopped the reaction, cooled to room temperature, filtered, the filtrate was concentrated under reduced pressure to recover excess 1,3-propanediol monomethyl ether, and the oily substance 4-(3-methoxypropoxy) - 11.2 g of 2,3-dimethyl-N-pyridine oxide, yield: 53.2%, directly put into the next step for reaction.

Embodiment 3

[0106] Example 3 Preparation of 4-(3-methoxypropoxy)-2-hydroxymethyl-3-methyl-pyridine

[0107] Add 21.1g (100mol) of 4-(3-methoxypropoxy)-2,3-dimethyl-N-pyridine oxide and 200ml acetic anhydride to a dry reaction flask, heat up to 60°C and stir for reaction 1 After 2 hours, the acetic anhydride was distilled off under reduced pressure, 150ml of 2N sodium hydroxide solution was added to the residue, stirred and reacted at 40°C for 4 hours, extracted with chloroform (100ml×3), dried and concentrated to obtain 14.8g of oil, yield 70.2%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines, and in particular relates to a benzimidazole derivative containing pyridine substituted by alkoxy as well as pharmaceutically acceptable salts or isomers thereof shown in a general formula (I), wherein R<1>, R<2>, R<3>, R<4>, R<5> and n are defined as the specification. The invention also relates to a method for preparing the compounds and a pharmaceutical composition containing the compounds, and application of the compounds to preparing the medicines for treating and / or preventing peptic ulcer.

Description

1. Technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to benzimidazole derivatives containing pyridine substituted by alkoxy groups, pharmaceutically acceptable salts and isomers thereof, methods for preparing these compounds, and pharmaceutical compositions containing these compounds , and the application of these compounds in the preparation of medicines for treating and / or preventing peptic ulcer. 2. Background technology [0002] Digestive system disease is one of common and frequently-occurring diseases, wherein the ulcer disease sickness rate accounts for about 10%~12% of the total population. The initial treatment is mainly to use antacids (such as sodium bicarbonate, aluminum hydroxide, etc.) to neutralize gastric acid to relieve symptoms. After the 1970s, with the H 2 The discovery of gastric acid secretion inhibitors such as receptor blockers and proton pump inhibitors has created a new era of peptic ulcer t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D401/12A61K31/4439A61P1/04
CPCY02P20/55
Inventor 黄振华
Owner SHANDONG XUANZHU PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com